Every finding on this page is sourced directly from BC Ministry of Health official releases, PharmaCare published data, and government-confirmed investigative findings. Medisyns does not manufacture the problem — it is documented in official records.
Source integrity policy: Every statistic on this page is cited with its primary source URL. We do not use secondary sources, industry estimates, or aggregator sites. If a number cannot be traced to a government document, auditor report, or peer-reviewed study, it does not appear here. Sources are dated — where data is from an earlier audit, this is noted explicitly.
A BC Ministry of Health internal investigative unit briefing, confirmed authentic by Health Minister Josie Osborne in February 2025, states that a "significant portion" of prescribed opioids in BC are being diverted and that prescribed alternatives are being trafficked provincially, nationally, and internationally. The investigation involves organized criminals, doctors, assisted living residences, and pharmacies.
Since 2024, the BC Ministry of Health's Special Investigative Unit, in collaboration with the College of Pharmacists of BC and law enforcement, has been investigating pharmacies suspected of illegal activities — including misusing fee-for-service payments to offer kickbacks to attract patients, and filling prescriptions patients did not require in order to overbill PharmaCare. More than 60 pharmacies have been identified.
Total BC PharmaCare expenditure in 2023/24 was $1.698 billion across 46.64 million paid claims for 1.01 million beneficiaries. PharmaNet — BC's province-wide pharmacy network — records every dispense in BC community pharmacies. Despite this infrastructure, the Ministry's own investigative unit found systematic fraud across more than 60 pharmacies that PharmaNet data alone did not prevent.
In December 2025, BC required all prescribed alternatives clients to transition to witnessed dosing — meaning patients must consume medications under direct supervision of a health professional. This policy reversal was a direct response to the confirmed diversion of prescribed opioids at scale. The BC government explicitly acknowledged that the fee structure for pharmacies had created financial incentives for bad actors to attract and retain patients fraudulently.
Context note: The BC findings are primarily drawn from the 2025 Ministry of Health investigation into prescribed alternatives diversion — a specific program within PharmaCare. The broader prescription drug verification gap (duplicate prescriptions, cross-system fraud, eligibility verification) remains a separate and unresolved issue across all PharmaCare plans. BC's PharmaNet provides transaction data but not real-time cross-party verification of the kind Medisyns provides.
BC has PharmaNet — a province-wide dispensing record system. But PharmaNet records transactions; it does not verify eligibility across parties in real time before dispensing occurs. The Ministry's own investigation found that systematic fraud at 60+ pharmacies went undetected until a Special Investigative Unit intervened. Medisyns sits at the verification layer — every fill is cross-checked against the prescriber registry, insurer eligibility, and cross-pharmacy duplication before the drug is dispensed.
PharmaNet records what happened. Medisyns verifies before it happens — catching incentive schemes and duplicate fills at the point of authorization.
BC has multiple PharmaCare plans plus private insurers. Medisyns connects all parties to a single real-time verification event per fill.
Every transaction logged on a permissioned ledger — immutable, timestamped, and auditable by the Ministry, College of Pharmacists, and law enforcement.
Medisyns is in active conversations with provincial health systems. If you work in or with provincial health policy, procurement, or health IT — we'd like to talk.